IKT
Inhibikase Therapeutics Inc
2.10$
-1.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.1% | -6.1% | 17.7% | -30.1% | -161.7% | -461.1% | -14,056.3% | -6,942.4% | – | – | |
| – | – | – | – | – | 0.0% | 5.4% | 68.1% | – | – | |
| 32.1% | 14.6% | 15.9% | 128.0% | 82.1% | 49.4% | 371.1% | 192.0% | – | – | |
| 31.9% | 16.6% | 33.4% | 192.5% | 312.6% | 72.7% | – | – | – | – | |
| 20.0% | -1.6% | 37.5% | 145.3% | -66.5% | -56.9% | 138.7% | 90.1% | – | – | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 197.1% | 5.5% | – | – | |
| 9.0% | 4.2% | 2.2% | – | – | – | -12,966.4% | 4,474.7% | – | – | |
| – | – | – | – | – | 2.5% | – | – | – | – | |
| – | – | – | – | – | -2.5% | – | – | – | – | |
| -2.5% | 6.4% | -0.7% | -2.0% | 39.1% | -1.4% | -201.6% | 0.0% | – | – | |
| -2.5% | 6.4% | -10.9% | -2.0% | 2,156.8% | 1,325.3% | -165.9% | 3,226.5% | – | – | |
| -5.5% | 0.2% | 9.0% | -32.2% | 1,995.1% | 864.2% | -27,188.6% | 758.8% | – | – | |
| -3.1% | -6.1% | 17.7% | -30.1% | -161.7% | -461.1% | -14,253.4% | -6,947.9% | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.